Craft

Illumina

Stock Price

$146

2024-10-29

Market Capitalization

$23.3 B

2024-10-29

Revenue

$4.3 B

FY, 2025

Illumina Summary

Company Summary

Overview
Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. Its products include microarray scanners, reagents, barcoded tubes, hybridization chambers, in-vitro diagnostic instruments, etc. The company caters to education, government, hospitals, pharmaceutical, commercial, and other industries.
Type
Public
Status
Active
Founded
1998
HQ
San Diego, CA, US | view all locations
Website
https://www.illumina.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jacob Thaysen

    Jacob Thaysen, Chief Executive Officer

  • Steve Barnard

    Steve Barnard, Chief Technology Officer

  • Kevin Pegels

    Kevin Pegels, Chief of Global Operations

  • Pat Leckman

    Pat Leckman, Chief People Officer

Operating MetricsView all

Backlog

$657M

FY, 2024

Facilities Leased, sq. ft.

2.4M
13.0%

FY, 2024

LocationsView all

32 locations detected

  • San Diego, CA HQ

    United States

    5200 Illumina Way

  • Baltimore, MD

    United States

    801 w . baltimore st, suite 500

  • Foster City, CA

    United States

    500 Lincoln Centre Dr

  • Madison, WI

    United States

    524 Genomic Drive

  • Melbourne, VIC

    Australia

    Level 3/535 Elizabeth St

  • Wien, Wien

    Austria

    Millennium Tower, Handelskai 94-96

and 26 others

Illumina Financials

Summary Financials

Revenue (Q1, 2026)
$1.1B
Gross profit (Q1, 2026)
$721.0M
Net income (Q1, 2026)
$134.0M
Cash (Q1, 2026)
$811.0M
EBIT (Q1, 2026)
$209.0M
Enterprise value
$24.9B

Footer menu